Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Building the Hybrid Cloud
- Connected Government: How to Build and Procure Network Services for the Future
- Continuing Diagnostics and Mitigation: Discussion of Progress and Next Steps
- Federal Executive Forum
- Federal Tech Talk
- The Future of Government Data Centers
- The Future of IT: How CIOs Can Enable the Service-Oriented Enterprise
- The Intersection: Where Technology Meets Transformation
- Maximizing ROI Through Data Center Consolidation
- Moving to the Cloud. What's the best approach for me
- Navigating Tough Choices in Government Cloud Computing
- The New Generation of Database
- Satellite Communications: Acquiring SATCOM in Tight Times
- Targeting Advanced Threats: Proven Methods from Detection through Remediation
- Transformative Technology: Desktop Virtualization in Government
- The Truth About IT Opex and Software Defined Networking
- Value of Health IT
- Air Traffic Management Transformation Report
- Cloud First Report
- General Dynamics IT Enterprise Center
- Gov Cloud Minute
- Government in Technology Series
- Homeland Security Cybersecurity Market Report
- National Cybersecurity Awareness Month
- Technology Insights
- The Cyber Security Report
- The Next Generation Cyber Security Experts
Shows & Panels
FDA approves easy-to-use heroin overdose antidote
Sunday - 4/6/2014, 9:10am EDT
WASHINGTON (AP) -- Friends and family will be able to take the first step to save a loved one from an overdose of heroin or powerful painkillers called opioids.
The Food and Drug Administration on Thursday approved an easy-to-use device that automatically injects the right dose of an overdose antidote named naloxone before an ambulance arrives. Doctors could prescribe it for family members or caregivers to keep on hand, in a pocket or a medicine cabinet.
Opioids include legal prescription painkillers, such as OxyContin and Vicodin, as well as illegal street drugs like heroin.
Called Evzio, the device contains naloxone, a long-used antidote for overdoses that is usually administered by syringe in ambulances or emergency rooms. But with the rise in drug overdose deaths, there has been a growing push to equip more people with the protection.
The FDA said Evzio's design makes it easy for anyone to administer. Once Evzio is turned on, it provides verbal instructions, much like defibrillators that laymen frequently use to help people who collapse with cardiac arrest. It is about the size of a credit card or small cellphone.
The antidote is not a substitute for immediate medical care, the FDA said, as anyone who has overdosed will need additional treatment.
Still uncertain is how much the antidote will cost. Executives of the drug's manufacturer, kaléo, Inc., of Richmond, Va., said it is too soon to say, but they are working with health insurers to get broad coverage.
Eric Edwards of kaléo says the antidote is intended not just for heroin or prescription drug addicts, but also for people who have accidental overdoses, unexpected drug interactions or are on very high doses of the drugs. People who overdose may suffer slower breathing or heart rates or loss of consciousness.
FDA Commissioner Margaret Hamburg said in a statement that 16,000 people die every year due to opioid-related overdoses, and that drug overdose deaths are now the leading cause of injury death in the United States, surpassing motor vehicle crashes. She said the increase in overdose deaths has largely been driven by prescription drug overdoses.
"While the larger goal is to reduce the need for products like these by preventing opioid addiction and abuse, they are extremely important innovations that will help to save lives," Hamburg said.
The announcement follows several state efforts to widen access to the antidote. At least 17 states and the District of Columbia now allow naloxone -- commonly known by the brand name Narcan -- to be distributed to the public. Some of those states allow for third parties, such as a family member or friend of an intravenous drug user, to be prescribed it. On Thursday, the state of New York announced that every state and local law enforcement officer will now carry syringes and inhalers of naloxone.
Police in Quincy, Mass., have been carrying naloxone nasal spray since 2010 and said in July 2013 that they used naloxone 179 times, reversing 170 of those overdoses -- a 95 percent success rate.
Some have questioned the idea, however. Maine Gov. Paul LePage has opposed a bill that would allow health care professionals to prescribe it for caregivers and family members and allow more emergency responders to carry the drug, saying it could raise Medicaid costs. He vetoed a similar bill last year, arguing that it could provide a false sense of security that abusers are somehow safe if they have a prescription nearby.
Health and Human Services Secretary Kathleen Sebelius said that making the antidote more available is part of a comprehensive government strategy to reduce opioid addictions, along with educating the medical community about signs of possible problems and reducing illegal access to the drugs.
Attorney General Eric Holder also weighed in on heroin abuse Thursday, telling a Senate committee that the government needs to deal differently with the heroin epidemic than it did with the crack cocaine crisis decades ago, when police focused on large-scale arrests and imprisonment.
Holder said the government has a small window to prevent the heroin problem from getting "even more out of control than it already is," saying specialized drug courts within the criminal justice system are a good way to reduce the prison population.
Associated Press Writers Eric Tucker in Washington, Alanna Durkin in Augusta, Maine, and Josefa Velasquez in Albany, N.Y. contributed to this report.
Follow Mary Clare Jalonick on Twitter: http://twitter.com/mcjalonick
Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.